Truist Securities Reiterates Buy Rating on Voyager Therapeutics (VYGR)
Tweet Send to a Friend
Truist Securities analyst Joon Lee reiterated a Buy rating and $18.00 price target on Voyager Therapeutics (NASDAQ: VYGR).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
